Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-22T07:23:40.376Z Has data issue: false hasContentIssue false

Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  29 January 2018

Rosemarie V. Cope*
Affiliation:
Barnsley Hall Hospital, Bromsgrove, Worcestershire B61 0EX
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © 1983 The Royal College of Psychiatrists 

References

Allen, R. C. & White, H. C. (1972) Side effects of long-acting phenothiazines. British Medical Journal, i, 807.Google Scholar
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 7983.Google Scholar
Cohen, W. J. & Cohen, N. H. (1974) Lithium carbonate, haloperidol and irreversible brain damage. Journal of the American Medical Association, 230, 1283–7.Google ScholarPubMed
Cope, R. V. & Gregg, E. M. (1983) The neuroleptic malignant syndrome. British Medical Journal, 286, 1938.Google Scholar
Delay, J., Pichot, P. & Lemperiere, T. (1960) Un neuroleptique majeur non phenothiazine et non reserpinique l'haloperidol dans le traitment des psychoses. Annates Medico-Psychologiques, 118, 145–52.Google Scholar
Itoh, M., Ohtsuka, N. & Ogita, K. (1977) Malignant Neuroleptic Syndrome: its present status in Japan and clinical problems. Folia Psychiatrica et Neurologica Japonica, 31, 565–76.Google ScholarPubMed
Meltzer, H. Y. (1973) Rigidity, hyperpyrexia and coma following fluphenazine enanthate. Psychopharmacologia, 29, 337–46.CrossRefGoogle ScholarPubMed
Smego, R. A. & Durack, D. T. (1982) The Neuroleptic Malignant Syndrome. Archives of Internal Medicine, 142, 1183–5.Google Scholar
Stauder, K. H. (1934). Die tödliche katatonia. Archiv für Psychiatrie und Nervenkrankheiten, 102, 614–34.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.